{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:58:24Z","timestamp":1791291504623,"version":"4.3.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12031-020-01779-2","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T16:32:02Z","timestamp":1613061122000},"page":"2353-2363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["MiR-27a-3p\/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1"],"prefix":"10.1007","volume":"71","author":[{"given":"Hongyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-8860","authenticated-orcid":false,"given":"Quantang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"1779_CR1","doi-asserted-by":"publisher","first-page":"9169","DOI":"10.1038\/s41598-019-42364-x","volume":"9","author":"T An","year":"2019","unstructured":"An T et al (2019) Comparison of Alterations in miRNA Expression in Matched Tissue and Blood Samples during Spinal Cord Glioma Progression Scientific reports 9:9169. https:\/\/doi.org\/10.1038\/s41598-019-42364-x","journal-title":"Comparison of Alterations in miRNA Expression in Matched Tissue and Blood Samples during Spinal Cord Glioma Progression Scientific reports"},{"key":"1779_CR2","doi-asserted-by":"publisher","unstructured":"Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y (2006) The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1 Clinical cancer research : an official journal of the American Association for Cancer Research 12:5533\u20135542.\u00a0https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0792","DOI":"10.1158\/1078-0432.Ccr-06-0792"},{"key":"1779_CR3","first-page":"305","volume":"60","author":"AJ Cappione","year":"1997","unstructured":"Cappione AJ, French BL, Skuse GR (1997) A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am J Hum Genet 60:305\u2013312","journal-title":"Am J Hum Genet"},{"key":"1779_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/b978-0-444-64076-5.00051-x","volume":"148","author":"PJ Cimino","year":"2018","unstructured":"Cimino PJ, Gutmann DH (2018) Neurofibromatosis type 1. Handb Clin Neurol 148:799\u2013811. https:\/\/doi.org\/10.1016\/b978-0-444-64076-5.00051-x","journal-title":"Handb Clin Neurol"},{"key":"1779_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/path.5187","volume":"247","author":"MA Frassanito","year":"2019","unstructured":"Frassanito MA et al (2019) Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes. J Pathol 247:241\u2013253. https:\/\/doi.org\/10.1002\/path.5187","journal-title":"J Pathol"},{"key":"1779_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/neuonc\/nos124","volume":"14","author":"M Gong","year":"2012","unstructured":"Gong M, Ma J, Li M, Zhou M, Hock JM, Yu X (2012) MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro-oncology 14:1007\u20131017. https:\/\/doi.org\/10.1093\/neuonc\/nos124","journal-title":"Neuro-oncology"},{"key":"1779_CR7","doi-asserted-by":"crossref","unstructured":"Gutmann DH et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. Jama 278:51\u201357","DOI":"10.1001\/jama.278.1.51"},{"key":"1779_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/hmg\/4.8.1267","volume":"4","author":"S Hoffmeyer","year":"1995","unstructured":"Hoffmeyer S, Assum G, Griesser J, Kaufmann D, Nurnberg P, Krone W (1995) On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1. Hum Mol Genet 4:1267\u20131272. https:\/\/doi.org\/10.1093\/hmg\/4.8.1267","journal-title":"Hum Mol Genet"},{"key":"1779_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0888-7543(95)80104-t","volume":"25","author":"Y Li","year":"1995","unstructured":"Li Y et al (1995) Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25:9\u201318. https:\/\/doi.org\/10.1016\/0888-7543(95)80104-t","journal-title":"Genomics"},{"key":"1779_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/1471-2164-14-473","volume":"14","author":"J Masliah-Planchon","year":"2013","unstructured":"Masliah-Planchon J et al (2013) MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis BMC. Genomics 14:473. https:\/\/doi.org\/10.1186\/1471-2164-14-473","journal-title":"Genomics"},{"key":"1779_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/00005072-199511000-00001","volume":"54","author":"LJ Metheny","year":"1995","unstructured":"Metheny LJ, Cappione AJ, Skuse GR (1995) Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I. J Neuropathol Exp Neurol 54:753\u2013760. https:\/\/doi.org\/10.1097\/00005072-199511000-00001","journal-title":"J Neuropathol Exp Neurol"},{"key":"1779_CR12","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41467-018-03962-x","volume":"9","author":"S Ottaviani","year":"2018","unstructured":"Ottaviani S et al (2018) TGF-\u03b2 induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Nat Commun 9:1845. https:\/\/doi.org\/10.1038\/s41467-018-03962-x","journal-title":"Nat Commun"},{"key":"1779_CR13","first-page":"994","volume":"145","author":"VM Riccardi","year":"1994","unstructured":"Riccardi VM, Womack JE, Jacks T (1994) Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol 145:994\u20131000","journal-title":"Am J Pathol"},{"key":"1779_CR14","doi-asserted-by":"publisher","unstructured":"Rouhi A, Mager DL, Humphries RK, Kuchenbauer F (2008) MiRNAs, epigenetics, and cancer Mammalian genome : official journal of the International Mammalian Genome Society 19:517\u2013525.\u00a0https:\/\/doi.org\/10.1007\/s00335-008-9133-x","DOI":"10.1007\/s00335-008-9133-x"},{"key":"1779_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/hmg\/6.10.1707","volume":"6","author":"GR Skuse","year":"1997","unstructured":"Skuse GR, Cappione AJ (1997) NA processing and clinical variability in neurofibromatosis type I (NF1). Hum Mol Genet 6:1707\u20131712","journal-title":"Hum Mol Genet"},{"key":"1779_CR16","doi-asserted-by":"publisher","first-page":"36137","DOI":"10.18632\/oncotarget.16661","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X et al (2017) Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21\/VEGF signal. Oncotarget 8:36137\u201336148. https:\/\/doi.org\/10.18632\/oncotarget.16661","journal-title":"Oncotarget"},{"key":"1779_CR17","doi-asserted-by":"publisher","first-page":"12926","DOI":"10.1002\/jcp.27959","volume":"234","author":"X Wang","year":"2019","unstructured":"Wang X et al (2019) LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy. J Cell Physiol 234:12926\u201312933. https:\/\/doi.org\/10.1002\/jcp.27959","journal-title":"J Cell Physiol"},{"key":"1779_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbrc.2018.02.144","volume":"498","author":"Q Xu","year":"2018","unstructured":"Xu Q, Cui Y, Luan J, Zhou X, Li H, Han J (2018) Exosomes from C2C12 myoblasts enhance osteogenic differentiation of MC3T3-E1 pre-osteoblasts by delivering miR-27a-3p . Biochem Biophys Res Commun 498:32\u201337. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.144","journal-title":"Biochem Biophys Res Commun"},{"key":"1779_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3892\/ijo.2012.1742","volume":"42","author":"W Xu","year":"2013","unstructured":"Xu W et al (2013) miR-24\u20133p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42:757\u2013766. https:\/\/doi.org\/10.3892\/ijo.2012.1742","journal-title":"Int J Oncol"},{"key":"1779_CR20","doi-asserted-by":"publisher","unstructured":"Yang X et al (2019) MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Bioscience Rep 39. https:\/\/doi.org\/10.1042\/bsr20191087","DOI":"10.1042\/bsr20191087"},{"key":"1779_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/path.4294","volume":"232","author":"P Zhang","year":"2014","unstructured":"Zhang P et al (2014) EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. J Pathol 232:308\u2013318. https:\/\/doi.org\/10.1002\/path.4294","journal-title":"J Pathol"},{"key":"1779_CR22","doi-asserted-by":"publisher","unstructured":"Zhao B, Zhang J, Chen X, Xu H, Huang B (2019) Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer Archives of medical science : AMS 15:498\u2013503.\u00a0https:\/\/doi.org\/10.5114\/aoms.2018.73315","DOI":"10.5114\/aoms.2018.73315"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:18:06Z","timestamp":1636676286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1779"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01779-2","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"19 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare no relevant conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The human tissues utilized in the study were collected under the subject protocol approved by Institutional Review Boards of Rongcheng People\u2019s Hospital of Shandong Province.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was provided by each subject or subject\u2019s guardian.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The publication was approved by all the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}